NEWS AND VIEWS FROM THE PHARMACEUTICAL FINE CHEMICAL AND CUSTOM MANUFACTURING SECTOR

Monday 8 June 2009

Synthetech reports boost in earnings, gloomy outlook

Synthetech saw its earnings rise from $113,000 to $657,000 in its fourth quarter. However the company said the biopharmaceuticals market is showing some weakness, the difficult financing environment could impair drug development projects and that some major pharmaceutical companies are reducing their outsourcing expenses.
Portland Business Journal

No comments: